106 related articles for article (PubMed ID: 3092346)
21. Anti-F(ab')2 antibodies that interfere with interpretation of the anti-C3 assay for immune complexes in children with rheumatic diseases.
Olds LC; Miller JJ
Arthritis Rheum; 1984 Mar; 27(3):330-6. PubMed ID: 6704194
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of circulating immune complexes in human serum by the Raji cell and F(ab')2 anti-C3 micro enzyme immunoassays.
Jordan SC; Gautier E; Sakai R; Bahn L
J Immunol Methods; 1985 Nov; 83(2):363-70. PubMed ID: 3902980
[TBL] [Abstract][Full Text] [Related]
23. Production and characterization of anti-human IgG F(ab')2 antibody fragment.
Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Abdolalizadeh J; Esparvarinha M; Majidi J
Hum Antibodies; 2018; 26(4):171-176. PubMed ID: 29689714
[TBL] [Abstract][Full Text] [Related]
24. Association of anti-F (ab')2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays.
Davey MP; Korngold L
Int Arch Allergy Appl Immunol; 1982; 67(3):278-83. PubMed ID: 6977496
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of circulating immune complexes in patients with metastatic breast cancer].
Krieger G; Kehl A; Bause I; Kneba M; Nagel GA
Klin Wochenschr; 1982 Dec; 60(23):1465-72. PubMed ID: 7154620
[TBL] [Abstract][Full Text] [Related]
26. A simple method for determining polymeric IgA-containing immune complexes.
Sancho J; Egido J; González E
J Immunol Methods; 1983 Jun; 60(3):305-17. PubMed ID: 6343503
[TBL] [Abstract][Full Text] [Related]
27. The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.
Lachmann PJ; Macanovic M; Harkiss GD; Oldroyd RG; Habicht J
Clin Exp Immunol; 1981 Nov; 46(2):250-8. PubMed ID: 6279342
[TBL] [Abstract][Full Text] [Related]
28. Immune complexes with antiglobulin activity in sera of Moloney sarcoma-bearing rats.
Balint JR
Clin Exp Immunol; 1982 Apr; 48(1):70-8. PubMed ID: 6979450
[TBL] [Abstract][Full Text] [Related]
29. Reactivity with patient antibodies of partially purified gp40 antigen from immune complexes in Burkitt's lymphoma and nasopharyngeal carcinoma.
Gazitt Y; Klein G; Sulitzeanu D
Int J Cancer; 1982 Jun; 29(6):645-51. PubMed ID: 7107067
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against gp140, the Epstein-Barr virus and C3d receptor in sera from rheumatoid arthritis patients.
Barel M; Kahan A; Charriaut-Marlangue C; Kahan A; Frade R
Eur J Immunol; 1986 Nov; 16(11):1357-61. PubMed ID: 2946590
[TBL] [Abstract][Full Text] [Related]
31. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
32. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
[TBL] [Abstract][Full Text] [Related]
33. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
[TBL] [Abstract][Full Text] [Related]
34. Anti-DNA activity in Raji cell eluates of sera from patients with systemic lupus erythematosus.
Tomii M
Ryumachi; 1981; 21 Suppl():123-7. PubMed ID: 6979800
[No Abstract] [Full Text] [Related]
35. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
[TBL] [Abstract][Full Text] [Related]
36. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.
Theofilopoulos AN; Bokisch VA; Dixon FJ
J Exp Med; 1974 Mar; 139(3):696-711. PubMed ID: 4591176
[TBL] [Abstract][Full Text] [Related]
37. Circulating IgA immune complexes in patients with psoriasis.
Hall RP; Peck GL; Lawley TJ
J Invest Dermatol; 1983 Jun; 80(6):465-8. PubMed ID: 6602187
[TBL] [Abstract][Full Text] [Related]
38. Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum.
Jones RG; Landon J
J Immunol Methods; 2002 May; 263(1-2):57-74. PubMed ID: 12009204
[TBL] [Abstract][Full Text] [Related]
39. Binding to histone of an anomalous IgG from patients with SLE and drug-induced lupus.
Teodorescu M; Ustiyan V; Russo K; Rubin RL
Clin Immunol; 2004 Feb; 110(2):145-53. PubMed ID: 15003811
[TBL] [Abstract][Full Text] [Related]
40. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
